Takakura S

No ORCID on file · 7 papers in corpus · active 2007-2026

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 2
2026
Gynecologic oncology reports ·doi:10.1016/j.gore.2026.102114

Gynecologic neuroendocrine carcinoma (NEC) is a rare and aggressive malignancy with limited treatment options and poor prognosis. Homologous recombination deficiency (HRD) is an established predictive biomarker for poly(ADP-ribose) polymera…

2025
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox14060670

Preterm birth and low birth weight remain major contributors to neonatal morbidity and mortality, yet the underlying mechanisms are not fully understood. Maternal microbiota has been implicated in adverse pregnancy outcomes, but key mediato…

2023
Cureus ·doi:10.7759/cureus.43330

A 44-year-old woman with an unremarkable medical history presented to another hospital complaining of lower abdominal pain and nausea. The clinical presentation was consistent with an acute abdomen, raising suspicion of gastrointestinal tra…

2017
Gynecology and Minimally Invasive Therapy ·doi:10.1016/j.gmit.2016.04.002

A uterine artery pseudoaneurysm (UAP) can occur after a traumatic event to the uterus, and cause massive bleeding. A uterine manipulator has been widely used for gynecologic laparoscopic surgery as basically an atraumatic instrument. We des…

2016
PloS one ·doi:10.1371/journal.pone.0162584

Previous studies have identified microRNA (miRNA) involvement in human cancers. This study aimed to elucidate potential clinical and biological associations of ovarian cancer-related miRNA gene expression profiles in high-grade serous carci…

other 2015
PloS one ·doi:10.1371/journal.pone.0116977

When compared with other epithelial ovarian cancers, the clinical characteristics of ovarian clear cell adenocarcinoma (CCC) include 1) a higher incidence among Japanese, 2) an association with endometriosis, 3) poor prognosis in advanced s…

article 2007
Oncology reports ·doi:10.3892/or.17.6.1333

We previously reported that indoleamine-2,3-dioxygenase (IDO) is associated with paclitaxel resistance and that IDO serves as a marker of poor prognosis in ovarian serous adenocarcinomas (SA). In this study, to explore the role of IDO in th…